Diazyme Laboratories, Inc.

Home
United States
Poway, CA
Diazyme Laboratories, Inc.

Diazyme is a clinical chemistry reagent manufacturer that develops IVD assays for use on conventional open channel automated chemistry platforms.

05/20/2026

May is Blood Pressure Awareness Month – and it’s more than just knowing your numbers.

While blood pressure cuffs tell us how hard the heart is working, a deeper look at vascular biomarkers can reveal the why and help predict what’s next.

Here are three powerful biomarkers helping clinicians go beyond the basics:

✅ Homocysteine – Elevated levels can damage blood vessels, promote arterial stiffness, and contribute to rising blood pressure, especially in those with vitamin B deficiencies.

✅ hs-CRP – A sensitive marker of systemic inflammation. Chronic inflammation can worsen hypertension and signal a higher risk of heart disease.

✅ PLAC® (Lp-PLA2) – A specific indicator of vascular inflammation and plaque vulnerability. Particularly useful in patients with high blood pressure and hidden cardiovascular risk.

Understanding these markers offers a clearer picture of a patient’s cardiovascular health, beyond just systolic and diastolic values.

💡 Early detection = early intervention.

This month, let’s raise awareness not just for blood pressure itself, but for the underlying factors that silently drive it.

Learn more here: https://bit.ly/4t1PA3A

05/12/2026

May is Stroke Awareness Month – a time to shine a light on one of the leading causes of death and disability worldwide.

At Diazyme, we’re proud to support stroke prevention with our PLAC® Activity Test, the only FDA-cleared assay that measures Lp-PLA2 activity—an enzyme associated with vascular inflammation and increased risk of ischemic stroke.

Early detection can save lives. By identifying at-risk patients before an event occurs, the PLAC® Activity Test empowers healthcare providers to take proactive steps toward prevention.

Let’s work together to raise awareness, support early risk assessment, and ultimately reduce the burden of stroke in our communities.

🔬 Learn more about the PLAC® Activity Test: https://bit.ly/41YFh5e

05/01/2026

May is Lung Health Awareness Month — a reminder of the importance of early research and innovation in the fight against chronic respiratory diseases.

At Diazyme, we're proud to support the scientific community with tools that advance research into lung health. Our DZ-Lite™ MMP-1 and MMP-7 CLIA Kits are designed for the quantitative detection of matrix metalloproteinases, enzymes involved in tissue remodeling and inflammation often seen in chronic lung conditions such as COPD, IPF, and other interstitial lung diseases.

🔬 These assays are for research use only, supporting the development of new insights and potential breakthroughs in understanding lung disease progression and pathophysiology.

Learn more about Diazyme’s lung disease marker solutions:
🔗 https://bit.ly/48VFKJ8

04/28/2026

The future of biomarker diagnostics: Diazyme’s commitment to advancing lab medicine.

At Diazyme, we’re focused on shaping the future of biomarker diagnostics with cutting-edge solutions that help healthcare providers detect, diagnose, and manage diseases more effectively. Our commitment to innovation is driving the development of next-generation assays that enhance accuracy, streamline workflows, and improve patient outcomes.

As we look ahead, we remain dedicated to advancing lab medicine and providing the tools necessary for better, more proactive healthcare.

The future of diagnostics is here—and we’re proud to be at the forefront of it.

Discover how we’re driving lab innovation: https://bit.ly/36lKaaV

04/22/2026

The Diazyme Total Bile Acids Assay provides laboratories with a reliable and efficient solution for quantitative bile acid measurement in serum. With liquid stable reagents and results in as little as 8 minutes, laboratories can streamline testing while maintaining dependable performance.

Key advantages include:
✔ Minimal interference from triglycerides, bilirubin, and hemolysis
✔ Results in as little as 8 minutes
✔ Liquid stable reagents
✔ Flexible instrument parameters to support simplified implementation

Learn more about the assay and how it supports clinical laboratories:
🔗 https://bit.ly/4lRG3Ko

04/19/2026

Supporting Liver Health on World Liver Day

The liver plays a vital role in overall health, yet liver diseases often go undiagnosed until they reach advanced stages. At Diazyme, we’re committed to improving liver health diagnostics with innovative assays like the Total Bile Acid (TBA) assay and Adenosine Deaminase (ADA) assay, which are critical for the early detection and monitoring of liver function.

These advanced solutions equip healthcare professionals with the tools they need for accurate diagnoses and better patient outcomes.

This World Liver Day, let’s raise awareness about the importance of liver health and the role of diagnostics in prevention and early intervention.

Take a closer look at our complete Liver Health Panel: https://bit.ly/3N2sBms

04/14/2026

Closing the Gap in Diabetes Monitoring 🩺

Effective diabetes management requires more than just a single snapshot of blood sugar levels. By combining multiple diagnostic assays, clinicians can gain a comprehensive view of a patient’s glycemic control—both short-term and long-term.

🩸 Key Assays Working Well Together:
✅ HbA1c: Tracks average blood glucose over the past 2–3 months for long-term trends.
✅ 1,5-AG (1,5-Anhydroglucitol): Highlights short-term glycemic spikes and recent glucose variability.
✅ GSP (Glycated Serum Protein): Offers insights into glucose patterns over the past 2–3 weeks.

🔬 Why Combine These Assays?
Together, they provide a clearer picture of glycemic patterns, help identify risks, and guide personalized care strategies.

💡 Closing the gap in diabetes monitoring means having the full picture—one that empowers better decisions, earlier interventions, and improved outcomes.

View all Diabetic Markers - https://bit.ly/3A6C7SA

04/09/2026

Supporting Better Diabetes Management with Advanced Testing

Effective diabetes management starts with accurate monitoring. Diazyme’s Diabetic Markers Panel includes advanced HbA1c, Glycated Serum Protein (GSP), and 1,5-AG assays, providing a comprehensive view of both long-term and short-term glucose control. These markers give healthcare providers the insights they need to optimize patient care and improve outcomes.

With innovative diagnostics, we’re making early detection and proactive diabetes care more accessible. Learn more about how our solutions support better health management.

Learn More about our Diabetic Markers: https://bit.ly/3A6C7SA

#1,5AG

04/08/2026

New ESC/EAS Guidelines on Lp(a)

Recent ESC/EAS guidance highlights the growing importance of lipoprotein(a) in cardiovascular risk assessment.

Key takeaways:
✅ Lp(a) is recognized as a risk-enhancing factor
✅ Measurement is recommended at least once in all adults
✅ Elevated levels can help identify hidden cardiovascular risk
✅ Supports more informed risk stratification and management decisions

As clinical guidelines continue to evolve, incorporating Lp(a) testing into routine evaluation is becoming increasingly important for early risk identification.

Diazyme’s Lp(a) assay supports laboratories with fast, reliable measurement and efficient workflow integration.

Learn more about Diazyme’s Lp(a) assay:
➡️https://www.diazyme.com/cardiovascular-markers/liprotein-lp-a-assay/

Read more on the new guidance:
➡️https://www.hcplive.com/view/lipid-management-in-special-populations-from-2026-dyslipidemia-guidelines

➡️https://www.patientcareonline.com/view/new-dyslipidemia-guidelines-emphasize-ldl-c-targets-lp-screening-pcps

04/06/2026

Spotlight on Gastro Health Panel: Supporting GI Health

Gastrointestinal disorders can significantly impact a patient’s quality of life, and assessing key biomarkers can help guide effective management. Diazyme’s Gastro Health Panel provides essential markers that support healthcare providers in evaluating gut health and making informed decisions for patient care.

By delivering reliable and efficient testing solutions, we’re helping to advance proactive approaches to digestive health.

Let’s emphasize the importance of gut health and proactive care this month!

Address

12889 Gregg Court
Poway, CA
92064

Website

http://www.diazyme.com/

Alerts

Be the first to know and let us send you an email when Diazyme Laboratories, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Want your practice to be the top-listed Clinic in Poway?